一问到底丨如何用“药品追溯码”维护用药权益？六个原则须知道

Core Viewpoint - Starting from today, all designated medical institutions in China must scan the "drug traceability code" for drug sales, which is essential for medical insurance fund settlement. By January 1, 2026, all medical institutions are required to fully collect and upload drug traceability codes [1][10]. Drug Traceability Code Scanning Process - The process for scanning the drug traceability code involves accessing the National Medical Insurance Bureau's WeChat public account, selecting the service option, and entering the drug traceability information query page [1][2]. - The scanning results can yield four possible outcomes, ranging from no sales information found to multiple sales records indicating potential issues with the drug's legitimacy [3][4][5]. Types of Traceability Codes - Traceability codes are categorized into three levels: large code, medium code, and small code, each serving different packaging units and purposes [6][7][9]. - The smallest traceability code is assigned to individual boxes, while medium and large codes are used for larger packaging, facilitating easier verification for companies [9]. Implementation and Regulation - Since the nationwide implementation of drug traceability code collection began in 2024, a total of 39.885 billion traceability codes have been aggregated [10]. - The National Medical Insurance Bureau has identified and is addressing fraudulent activities related to the sale of "returned drugs" and other illegal practices [15][17]. Consumer Rights and Responsibilities - Consumers are advised to follow six principles when purchasing drugs to protect their rights, including ensuring the presence of a traceability code, verifying the code during payment, and retaining receipts [18].